1-9 of 9
S. Nati
Close
Sort by
Journal Articles

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

G. Pica, S. Vagge, G. Beltrami, S. Nati, G. Catania, R. Corvò, A. M. Carella, MD
Journal: Blood
Blood (2011) 118 (21): 4523.
https://doi.org/10.1182/blood.V118.21.4523.4523
Published: 2011
Journal Articles

Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study

G. Pica, S. Nati, Umberto Vitolo, MD, Sara Galimberti, Pier Luigi Zinzani, MD, PhD, Nicola Cascavilla, Mario Petrini, MD, A. M. Carella, MD
Journal: Blood
Blood (2011) 118 (21): 100.
https://doi.org/10.1182/blood.V118.21.100.100
Published: 2011
Journal Articles

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

A. M. Carella, G. Catania, G. Pica, G. Beltrami, S. Nati, R. Vimercati, A. Congiu, E. Rossi, M. Spriano
Journal: Blood
Blood (2009) 114 (22): 4109.
https://doi.org/10.1182/blood.V114.22.4109.4109
Published: 2009
Journal Articles

90 y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group

A. M. Carella, S. Nati, G. Fraternali Orcioni, M. Petrini, S. Galimberti, U. Vitolo, N. Cascavilla, P.L. Zinzani
Journal: Blood
Blood (2008) 112 (11): 3061.
https://doi.org/10.1182/blood.V112.11.3061.3061
Published: 2008
Journal Articles

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

A. M. Carella, E. Todisco, L. Castagna, A. Santoro, G. Catania, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano, R Varaldo
Journal: Blood
Blood (2008) 112 (11): 3294.
https://doi.org/10.1182/blood.V112.11.3294.3294
Published: 2008
Journal Articles

Late Platelets Recovery after Autografting (ASCT) in Patients with Acute Myeloid Leukemia (AML) Is A Prognostically Favourable Factor for Long-Term Remission

A. M. Carella, G Catania, R Varaldo, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano
Journal: Blood
Blood (2008) 112 (11): 4433.
https://doi.org/10.1182/blood.V112.11.4433.4433
Published: 2008
Journal Articles

Reduced-Intensity Conditioning for Allografting Following Autografting for Myeloma: Lower Relapse Rates Compared with Single or Double Autografting but Similar Overall Survival. The Genoa Experience in 74 Patients.

A.M. Carella, MD, G. Catania, MD, S. Biasco, MD, M. Congiu, MD, S. Nati, MD, E. Rossi, MD, R. Vimercati, MD, D. Ciapanna, MD, M. Spriano, MD
Journal: Blood
Blood (2007) 110 (11): 5095.
https://doi.org/10.1182/blood.V110.11.5095.5095
Published: 2007
Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Autografting Has Strong Anti-Myeloma Activity and Delays Disease Progression Compared to Tandem Autografting.

A.M. Carella, MD, E. Lerma, MD, Phd, S. Nati, MD, A. Congiu, MD, E. Rossi, MD, M. Spriano, MD, R. Vimercati, MD
Journal: Blood
Blood (2006) 108 (11): 51.
https://doi.org/10.1182/blood.V108.11.51.51
Published: 2006
Journal Articles

Autografting Followed Closely by Nonmyeloablative Allografting as Consolidation Immunotherapy Reduces Disease Progression Compared to Tandem Autografting in Multiple Myeloma.

A.M. Carella, MD, M. Spriano, MD, M. T. Corsetti, MD, P. Scalzulli, MD, G. Beltrami, MD, E. Lerma, MD, PhD, N. Cascavilla, MD, M. Carella, MD, S. Nati, MD, A. Congiu, MD, P. Musto, MD
Journal: Blood
Blood (2005) 106 (11): 1126.
https://doi.org/10.1182/blood.V106.11.1126.1126
Published: 2005